Selecta Biosciences

$3.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+4.73%) As of 11:16 AM EDT today

Why Robinhood?

You can buy or sell SELB and other stocks, options, and ETFs commission-free!

About SELB

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Read More The firm's proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA. The listed name for SELB is Selecta Biosciences, Inc. Common Stock.

Employees
39
Headquarters
Watertown, Massachusetts
Founded
2007
Market Cap
344.46M
Price-Earnings Ratio
Dividend Yield
Average Volume
6.02M
High Today
$3.27
Low Today
$2.95
Open Price
$2.98
Volume
2.10M
52 Week High
$4.83
52 Week Low
$1.29

Collections

SELB Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 6, Pre-Market

You May Also Like